Researchers discover a potential target for immunotherapy-resistant prostate cancers
Researchers at the University of Notre Dame have identified how a gene called Pygo2 makes some prostate cancers resistant to treatment with immunotherapy.
The Harper Cancer Research Institute is changing the way we fight cancer.
Located in South Bend, Indiana, HCRI researchers are dedicated to conducting innovative and integrative research that confronts the complex challenges of cancer. From common malignancies to rare and recalcitrant cancers, researchers at the University of Notre Dame and Indiana University School of Medicine - South Bend are united in multi-disciplinary teams with a common goal: to increase the survival of all patients diagnosed with cancer.
A collaboration between the University of Notre Dame and the Indiana University School of Medicine South Bend
University of Notre Dame and Indiana University School of Medicine, South Bend
Featured News More News
Harper Highway Clean-up
Potential requiem for a bacterium: Notre Dame biochemists Chang and Mobashery discover antibiotic that fights C. diff infection
Opportunities to Support Research on Notre Dame Day
Featured Events More Events
Featured Videos
